Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates
Locked nucleic acid (LNA) oligonucleotides have been successfully used to efficiently inhibit endogenous small noncoding RNAs in vitro and in vivo. We previously demonstrated that the direct miR-221 inhibition by the novel 13-mer LNA-i-miR-221 induces significant antimyeloma activity and upregulates...
Saved in:
Main Authors: | Maria Eugenia Gallo Cantafio (Author), Boye Schnack Nielsen (Author), Chiara Mignogna (Author), Mariamena Arbitrio (Author), Cirino Botta (Author), Niels M Frandsen (Author), Christian Rolfo (Author), Pierosandro Tagliaferri (Author), Pierfrancesco Tassone (Author), Maria Teresa Di Martino (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Scaling approaches for the prediction of human clearance of LNA-i-mir-221: A retrospective validation
by: Massimiliano Fonsi, et al.
Published: (2024) -
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats
by: Maria Teresa Di Martino, et al.
Published: (2020) -
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation
by: Asad Ali, et al.
Published: (2024) -
Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates
Published: (2016) -
BRCA1/2 genetic background-based therapeutic tailoring of human ovarian cancer: hope or reality?
by: Tagliaferri Pierosandro, et al.
Published: (2009)